Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24-week, randomized, double-blind study.

Bolli G, Dotta F, Rochotte E, Cohen SE.

Diabetes Obes Metab. 2008 Jan;10(1):82-90. Epub 2007 Nov 22.

PMID:
18034842
2.

Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes.

Bekiari E, Rizava C, Athanasiadou E, Papatheodorou K, Liakos A, Karagiannis T, Mainou M, Rika M, Boura P, Tsapas A.

Endocrine. 2016 Jun;52(3):458-80. doi: 10.1007/s12020-015-0841-1. Epub 2015 Dec 29. Review.

PMID:
26714458
3.

Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications.

De Oliveira GL, Guerra JĂșnior AA, Godman B, Acurcio FA.

Expert Rev Pharmacoecon Outcomes Res. 2017 Apr;17(2):109-119. doi: 10.1080/14737167.2017.1292852. Epub 2017 Feb 22. Review.

PMID:
28403729
4.
5.

Addendum to Commission A13-17 (Vildagliptin / Metformin) [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2013 Aug 29.

Supplemental Content

Support Center